| Old Articles: <Older 4491-4500 Newer> |
|---|
 |
Entrepreneur
February 2008
Kim Orr |
Smooth Operator Paul White developed a surgery system that cuts to the heart of the problem.   |
The Motley Fool
January 11, 2008
Brian Orelli |
Biochip Packaging: Some Settling May Occur Biochip maker Illumina settles its disputes about patents with Affymetrix. |
The Motley Fool
January 11, 2008
Brian Orelli |
Boston Scientific Lives Below Its Means Cost-cutting efforts should help turn the medical-device making company around in 2008. |
The Motley Fool
January 10, 2008
Brian Orelli |
Good News for Lucky Men Eli Lilly's erectile dysfunction drug can now be taken daily. |
InternetNews
January 9, 2008
Larry Barrett |
IBM, Mayo Clinic Open Imaging Research Center IBM's high-end imaging platforms and hardware will be used to improve the speed and clarity of medical images used by physicians and radiologists. |
The Motley Fool
January 9, 2008
Brian Orelli |
Sirtris' Diabetes Drug: Safe, but Is It Effective? Sirtris has exciting drugs, but is still a pretty risky investment. Investors, this may be one to keep an eye on. |
The Motley Fool
January 9, 2008
Brian Lawler |
Checking In on Biogen Biogen Idec presents at the JPMorgan Healthcare Conference, reiterating its long-term guidance of 15% compound annual sales growth and 20% average non-GAAP earnings-per-share growth from 2007 through 2010. |
The Motley Fool
January 9, 2008
Brian Lawler |
Tracking Genzyme The biopharma updates investors on what to expect for 2008. |
The Motley Fool
January 9, 2008
Brian Orelli |
Genzyme Buys Into Antisense RNA -- Big Time Genzyme buys a piece of Isis' mipomersen at a wowser of a price. |
The Motley Fool
January 8, 2008
Brian Lawler |
InterMune Goes Step by Step The company updates investors on the progress of its lead drug for hepatitis C. |
| <Older 4491-4500 Newer> Return to current articles. |
